Combining Noninvasive Brain Stimulation and Cognitive Training on Tobacco Craving

NCT ID: NCT02810574

Last Updated: 2016-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether combining noninvasive brain stimulation with cognitive training can reduce craving in adults with tobacco use disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active noninvasive brain stimulation and cognitive training

In active condition, subject will receive stimulation during all the 30-minute stimulation period combined with cognitive training.

Group Type ACTIVE_COMPARATOR

Cognitive training

Intervention Type BEHAVIORAL

Noninvasive brain stimulation (active)

Intervention Type DEVICE

Neuroconn DC-STIMULATOR PLUS

Sham noninvasive brain stimulation

In sham condition, subject will receive stimulation only during the first 30 seconds of the 30-minute stimulation period combined with cognitive training.

Group Type SHAM_COMPARATOR

Cognitive training

Intervention Type BEHAVIORAL

Noninvasive brain stimulation (sham)

Intervention Type DEVICE

Neuroconn DC-STIMULATOR PLUS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive training

Intervention Type BEHAVIORAL

Noninvasive brain stimulation (active)

Neuroconn DC-STIMULATOR PLUS

Intervention Type DEVICE

Noninvasive brain stimulation (sham)

Neuroconn DC-STIMULATOR PLUS

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 20-60 years old
* Smoking \> 15 cigarettes per day
* Tobacco Use Disorder according to Diagnostic and Statistical Manual V criteria

Exclusion Criteria

* Contraindications to noninvasive brain stimulation
* Psychiatric or neurologic condition
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Interdisciplinaire de Recherche en Réadaptation et Intégration

Québec, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marine Mondino, PhD

Role: CONTACT

418-529-9141 ext. 6915

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marine Mondino, PhD

Role: primary

418-529-9141 ext. 6915

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-336

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation in Hospitalized Smokers
NCT01289275 COMPLETED PHASE4